(Q53403417)

14 May 2018

title

Association of hypertension with small, dense low-density lipoprotein in patients without metabolic syndrome. (English)

1 reference

14 May 2018

1 reference

1 reference

Y K Kim

1

1 reference

14 May 2018

H S Seo

2

1 reference

14 May 2018

E M Lee

3

1 reference

14 May 2018

J O Na

4

1 reference

14 May 2018

C U Choi

5

1 reference

14 May 2018

H E Lim

6

1 reference

14 May 2018

E J Kim

7

1 reference

14 May 2018

S-W Rha

8

1 reference

14 May 2018

C G Park

9

1 reference

14 May 2018

D J Oh

10

1 reference

14 May 2018

publication date

6 October 2011

1 reference

14 May 2018

Journal of Human Hypertension

published in

1 reference

14 May 2018

volume

26

1 reference

14 May 2018

issue

11

1 reference

14 May 2018

page(s)

670-676

1 reference

14 May 2018

https://scigraph.springernature.com/pub.10.1038/jhh.2011.86

exact match

0 references

cites work

Chemical mediators of the muscle ergoreflex in chronic heart failure: a putative role for prostaglandins in reflex ventilatory control

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

Obesity, Metabolic Syndrome, and Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

Metabolic origins and clinical significance of LDL heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

Clinical review 163: Cardiovascular endocrinology: Low-density lipoprotein size and cardiovascular disease: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

Comparability of methods for LDL subfraction determination: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

Diabetic dyslipidaemia: insights for optimizing patient management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

Dyslipidaemia, hypercoagulability and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

Abnormal low-density lipoprotein subfraction profile in patients with untreated hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

Pioglitazone reduces atherogenic dense LDL particles in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

Influence of polymorphism (RFLP-sstI) at the apolipoprotein C-III gene locus on the lipoprotein metabolism and insulin resistance in essential hypertensive patients. Interaction between gender and genetic polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

7 January 2021

Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

7 January 2021

Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

7 January 2021

A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

7 January 2021

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

7 January 2021

Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

7 January 2021

Endothelial dysfunction in men with small LDL particles

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

7 January 2021

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

7 January 2021

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

7 January 2021

Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

7 January 2021

Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatment

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

7 January 2021

Lipoprotein lipase gene mutations and the genetic susceptibility of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

7 January 2021

Lipoprotein lipase variants associated with an endophenotype of hypertension: hypertension combined with elevated triglycerides

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

7 January 2021

Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.86

7 January 2021

Identifiers

DOI

10.1038/JHH.2011.86

1 reference

14 May 2018

Dimensions Publication ID

1034875003

0 references

1 reference

14 May 2018